Loading...
Loading...
TEVA| Name | Value |
|---|---|
| Revenues | 3,850.0M |
| Cost of Revenue | 1,999.0M |
| Gross Profit | 1,851.0M |
| Operating Expense | 1,097.0M |
| Operating I/L | 355.0M |
| Other Income/Expense | -280.0M |
| Interest Income | 0.0M |
| Pretax | 75.0M |
| Income Tax Expense | -12.0M |
| Net Income/Loss | 80.0M |
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that specializes in developing, manufacturing, marketing, and distributing generic medicines, specialty medicines, and biopharmaceutical products. The company offers a wide range of products including sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms. Teva focuses on therapeutic areas such as central nervous system, pain, respiratory, and oncology, offering products like Copaxone for multiple sclerosis, AJOVY for migraine prevention, and various respiratory medications. Additionally, the company also develops, manufactures, and sells active pharmaceutical ingredients, and has collaborations for the development and commercialization of long-acting injectable products.
